Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

ClinicalTrials.gov ID: NCT02477748

Public ClinicalTrials.gov record NCT02477748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Study identification

NCT ID
NCT02477748
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alcobra Ltd.
Industry
Enrollment
283 participants

Conditions and interventions

Interventions

  • MDX Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Dec 31, 2016
Completion
Dec 31, 2016
Last update posted
Jan 18, 2017

2015 – 2017

United States locations

U.S. sites
36
U.S. states
26
U.S. cities
35
Facility City State ZIP Site status
Harmonex, Inc. Dothan Alabama 36303
Pharmacology Research Institute Los Alamitos California 90720
Pharmacology Research Institute Newport Beach California 92660
Artemis Institute for Clinical Research San Diego California 92103
University of California, San Francisco San Francisco California 94143
MCB Clinical Research Centers Colorado Springs Colorado 80910
Connecticut Clinical Research Cromwell Connecticut 06416
Coastal Connecticut Research New London Connecticut 06320
Sarkis Clinical Trials Gainesville Florida 32607
Clinical Neuroscience Solutions Jacksonville Florida 32256
CNS Healthcare Orlando Florida 32801
Miami Research Associates South Miami Florida 33143
Institute for Advanced Medical Research Alpharetta Georgia 30005
Goldpoint Clinical Research Indianapolis Indiana 46260
Lake Charles Clinical Trials Lake Charles Louisiana 70629
Kennedy Krieger Institute Baltimore Maryland 21205
Rochester Center For Behavioral Medicine Rochester Hills Michigan 48307
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304
Premier Psychiatric Research Institute Lincoln Nebraska 68526
Center for Emotional Fitness Cherry Hill New Jersey 08002
Global Medical Institutes, LLC, Princeton Medical Institute Princeton New Jersey 08540
The Medical Research Network New York New York 10128
Richard H Weisler, MD, PA Raleigh North Carolina 27609
Neuro-Behavioral Clinical Research, Inc. Canton Ohio 44718
IPS Research Company Oklahoma City Oklahoma 73103
Village Clinical Research Inc Oklahoma City Oklahoma 73103
Summit Research Network Portland Oregon 97210
Suburban Research Associates Media Pennsylvania 19063
Carolina Clinical Research, Inc. Charleston South Carolina 29405
Clinical Neuroscience Solutions Memphis Tennessee 38119
BioBehavioral Research of Austin at Specialty Clinic of Austin Austin Texas 78759
Bayou City Research Houston Texas 77007
Psychiatric & Behavioral Solutions Salt Lake City Utah 84105
NeuroScience, Inc. (NSI) Herndon Virginia 20170
Summit Research Network(Seattle)LLC Seattle Washington 98104
Dean Foundation - Middleton Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02477748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02477748 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →